Roche cobas HPV test for cervical screening gets FDA nod for use on cobas 6800/8800 Systems
Swiss healthcare company Roche has bagged approval from the US Food and Drug Administration to use its cobas HPV test on the fully automated cobas ... Read More
Oxford University ChAdOx1 nCoV-19 vaccine trial begins in humans
Researchers at the University of Oxford in the UK have commenced the ChAdOx1 nCoV-19 vaccine trial in healthy human volunteers to test the vaccine candidate's ... Read More
TScan, Novartis to develop T cell receptor therapies for solid tumors
TScan Therapeutics has partnered with Swiss pharma giant Novartis to discover and develop novel TCR-engineered T cell receptor therapies for the treatment of solid tumors ... Read More
DNA-based COVID-19 vaccine candidate being developed by University of Waterloo
DNA-based COVID-19 vaccine candidate : Researchers at the University of Waterloo in Canada are developing a DNA-based vaccine candidate which can be given via nasal ... Read More
Incyte bags Pemazyre FDA approval for cholangiocarcinoma treatment
Pemazyre FDA approval : US biopharma company Incyte has bagged accelerated approval from the US Food and Drug Administration (FDA) for Pemazyre (pemigatinib) for the ... Read More
Vaccine giants Sanofi, GSK announce COVID-19 vaccine partnership
French pharma company Sanofi has announced a COVID-19 vaccine partnership with GlaxoSmithKline (GSK) to develop an adjuvanted vaccine for the novel coranavirus, by combining their ... Read More
Rutgers University’s saliva-based COVID-19 test gets FDA approval
New Jersey-based Rutgers University’s RUCDR Infinite Biologics and its collaborators have been granted emergency use authorization (EUA status) for their saliva-based COVID-19 test by the ... Read More
Sinovac Biotech gets approval to begin coronavirus vaccine trial
Coronavirus vaccine trial : Chinese biopharma company Sinovac Biotech has secured approval to carry out a human clinical trial on an inactivated COVID-19 vaccine candidate, ... Read More
Cyclica, Genome Institute of Singapore sign drug discovery partnership
Canadian biotech company Cyclica has signed a multi-year and multi-project drug discovery partnership with the Genome Institute of Singapore (GIS) in oncology and related diseases. ... Read More
Second EUA issued by FDA to decontaminate N95 respirators for reuse
The US Food and Drug Administration (FDA) has granted the second emergency use authorization (EUA) to decontaminate compatible N95 or N95-equivalent respirators for reuse by ... Read More